These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2494313)

  • 21. Beta-blockade in myocardial ischemia: acute interventions in myocardial infarction.
    Bleifeld WH
    J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S56-8. PubMed ID: 2468836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysrhythmias and blood pressure changes associated with thrombolysis.
    Lepley-Frey D
    Heart Lung; 1991 Jul; 20(4):335-41. PubMed ID: 1906443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolytic therapy in acute myocardial infarction: Part II--rt-PA.
    Mueller HS; Roberts R; Teichman SL; Sobel BE
    Med Clin North Am; 1989 Mar; 73(2):387-407. PubMed ID: 2493116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intracoronary tissue-type plasminogen activator treatment in kawasaki disease and acute myocardial infarction.
    Nakagawa M; Watanabe N; Okuno M; Okamoto N; Fujino H
    Cardiology; 2000; 94(1):52-7. PubMed ID: 11111145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs that dissolve clots.
    Braun AE
    RN; 1991 Jun; 54(6):52-7. PubMed ID: 1903557
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute consequences of ischemic myocardial damage.
    Hugenholtz PG; Serruys PW; Simoons ML; Vermeer F
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S1-11. PubMed ID: 2483224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracoronary thrombolysis: organizational prerequisites, technique, and results.
    Rutsch W; Schmutzler H
    Cardiovasc Intervent Radiol; 1986; 9(5-6):245-52. PubMed ID: 2948642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update: drug therapy for acute myocardial infarction.
    Brown JF; Valenzuela TD
    Compr Ther; 1991 May; 17(5):45-50. PubMed ID: 1879127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy for acute myocardial infarction: the elderly population.
    House MA
    AACN Clin Issues Crit Care Nurs; 1992 Feb; 3(1):106-13. PubMed ID: 1554550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-plasminogen activator: nursing implications.
    Briones TL
    Dimens Crit Care Nurs; 1989; 8(4):200-9. PubMed ID: 2505991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of neonatal myocardial infarction: left coronary artery thrombus resolution and normalisation of ventricular function by intracoronary low-dose tissue plasminogen activator.
    Hallbergson A; Gillespie MJ; Dori Y
    Cardiol Young; 2015 Apr; 25(4):810-2. PubMed ID: 25032721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nursing: AMI (acute myocardial infarct)].
    Buch T
    Sygeplejersken; 1991 Jan; 91(5):24-8. PubMed ID: 2063292
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolytic therapy orders and record sheets: nursing care made easier.
    Rafter RH
    J Emerg Nurs; 1988; 14(4):237-9. PubMed ID: 3137388
    [No Abstract]   [Full Text] [Related]  

  • 34. Early intravenous thrombolytic therapy for acute myocardial infarction in patients with prior coronary artery bypass grafts.
    Kleiman NS; Berman DA; Gaston WR; Cashion R; Roberts R
    Am J Cardiol; 1989 Jan; 63(1):102-4. PubMed ID: 2491770
    [No Abstract]   [Full Text] [Related]  

  • 35. Early hospital arrival and treatment of patients with acute myocardial infarction: practice management and your role in thrombolytic therapy. Introduction.
    Somelofski CA; Osguthorpe S
    Heart Lung; 1991 Sep; 20(5 Pt 2):535-7. PubMed ID: 1894536
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapies to limit infarct size. Timing, dosage, and effectiveness.
    Peterson JE; Emmot WW
    Postgrad Med; 1989 Sep; 86(3):54-9, 63. PubMed ID: 2505243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a new i.v. push t-PA?
    Sweeney E
    Heartbeat; 1990; 1(3):3. PubMed ID: 2127727
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolytic agents: a clinician's perspective.
    Solomon HA
    Am J Med; 1987 Aug; 83(2A):47-51. PubMed ID: 3631115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 40-year-old patient with an evolving extensive inferior MI treated with t-PA thrombolytic therapy.
    Denke NJ
    J Emerg Nurs; 1988; 14(6):334-7. PubMed ID: 3144621
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombus-specific/responsive biomimetic nanomedicine for spatiotemporal thrombolysis and alleviation of myocardial ischemia/reperfusion injury.
    Guo X; Hong T; Zang J; Shao R; Hou X; Wang K; Liu W; Su F; He B
    J Nanobiotechnology; 2022 Dec; 20(1):531. PubMed ID: 36514154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.